{
    "clinical_study": {
        "@rank": "16780", 
        "arm_group": [
            {
                "arm_group_label": "Control Arm", 
                "arm_group_type": "No Intervention", 
                "description": "This arm will perform the pulmonary rehabilitation as specified with no respiratory assistance."
            }, 
            {
                "arm_group_label": "Intervention Arm", 
                "arm_group_type": "Active Comparator", 
                "description": "This arm will conduct the pulmonary rehabilitation program with BiLevel Noninvasive Ventilation assistance from a ResMed ventilator."
            }
        ], 
        "brief_summary": {
            "textblock": "This trial hopes to demonstrate the effect of 4 weeks of outpatient exercise rehabilitation\n      on COPD patients. In particular the effect on:\n\n        -  the amount of daily physical activity\n\n        -  Quality of life\n\n        -  The 6-minute walk distance\n\n        -  Time to exacerbation\n\n      and compare it to the effect of 4 weeks of outpatients rehabilitation with Noninvasive\n      Ventilation as an adjunct therapy."
        }, 
        "brief_title": "The Effect of NIV on QoL and Exercise Capacity in a COPD Exercise Rehabilitation Program", 
        "completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Obstructive Pulmonary Disease", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of COPD III+IV\n\n          -  Age >18 years\n\n          -  Former NIV treatment for at least 6 weeks with a positive end-expiratory pressure of\n             at least 4 cmH2O and a pressure support of 8 cmH2O or higher\n\n        Exclusion Criteria:\n\n          -  Pulmonary Exacerbation requiring antibiotic treatment or hospitalization during the\n             last 6 weeks\n\n          -  non-pulmonary Exercise impairment (amputation, severe heart disease, etc)\n\n          -  any disease that precludes exercise training\n\n          -  inability to understand the patient information\n\n          -  substance abuse\n\n          -  oxygen requirement of more than 6l O2/min during exercise"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02100709", 
            "org_study_id": "RMD_NIV_COPD_001"
        }, 
        "intervention": {
            "arm_group_label": "Intervention Arm", 
            "description": "Positive pressure applied through an oro-nasal mask. The pressure is altered between inspiration and expiration.", 
            "intervention_name": "BiLevel Noninvasive Ventilation", 
            "intervention_type": "Device", 
            "other_name": [
                "NIV", 
                "BiPAP", 
                "Pressure Support Ventilation", 
                "PSV"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 31, 2014", 
        "location": {
            "contact": {
                "email": "Bjoern.Kleibrink@ruhrlandklinik.uk-essen.de", 
                "last_name": "Bj\u00f6rn Kleibrink", 
                "phone": "0201 433-4614"
            }, 
            "facility": {
                "address": {
                    "city": "Tuschen", 
                    "country": "Germany", 
                    "state": "Essen", 
                    "zip": "45239"
                }, 
                "name": "Ruhrlandklinik"
            }, 
            "investigator": [
                {
                    "last_name": "Bj\u00f6rn Kleibrink", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Helmut Teschler", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Gerhard Weinreich", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of BiLevel Pressure Support NonInvasive Ventilation on Quality of Life and Exercise Capacity in a COPD Exercise Rehabilitation Program", 
        "other_outcome": {
            "description": "The average time to exacerbation between groups will be analysed post trial.", 
            "measure": "Time to pulmonary exacerbation", 
            "safety_issue": "No", 
            "time_frame": "12 Months"
        }, 
        "overall_official": {
            "affiliation": "Dept. Respiratory & Sleep Medicine - Ruhrlandklinik", 
            "last_name": "Helmut Teschler, Prof. Dr. med.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Australia: Department of Health and Ageing Therapeutic Goods Administration"
            ]
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The primary outcome will be measured by daily activity using accelerometer arm bands. This will be measured at the beginning of the rehabilitation program, at the end and at a 3 month follow up.", 
                "measure": "Daily Physical Activity", 
                "safety_issue": "No", 
                "time_frame": "3 Months"
            }, 
            {
                "description": "6 Minute Walking Distance will be measured every week during the exercise program.", 
                "measure": "Exercise Capacity", 
                "safety_issue": "No", 
                "time_frame": "6 Weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02100709"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Using the St. George Respiratory Questionnaire before and after rehabilitation, quality of life will be measured.", 
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "3 Months"
            }, 
            {
                "description": "Change in Dyspnoea after end of exercise will be assessed using the Multidimensional Dyspnoea Profile and the BORG scale.", 
                "measure": "Dyspnoea", 
                "safety_issue": "No", 
                "time_frame": "6 Weeks"
            }, 
            {
                "description": "Maximum training intensity, body weight and muscle diameter will be tracked throughout the training program.", 
                "measure": "Change in Physiological Parameters", 
                "safety_issue": "No", 
                "time_frame": "3 Months"
            }
        ], 
        "source": "ResMed", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ResMed", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}